Biggest News Aggregation in the World
📰 Rom News

Page 332 - Rom News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Rom. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Zura Bio Completes Approximately $80 Million Financing with the Focus on Advancing ZB-106, a Potential First-in-class Anti-IL-17 and Anti-BAFF Dual Antagonist

Tibulizumab was licensed from Eli Lilly and Company on April 26, 2023 Total cash and cash equivalents of approximately $120 million is expected to fund planned clinical and operating activities... | June 6, 2023
Someit Sidhu Raymond James Eli Lilly Zura Bio Zura Bio Limited Nasdaq Exchange Commission

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science